Dupilumab as a targeted therapeutic strategy for Th2-driven cutaneous manifestations in Kimura disease
Dermatology Reports · 22.07.2026
DOI: 10.4081/dr.2026.10839 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatology Reports, online erschienen am 22.07.2026. Verfasst von Gaetano Licata und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Unit, San Antonio Abate Hospital, Trapani. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Dear Editor, Kimura disease (KD) is a rare, chronic inflammatory condition characterized by subcutaneous nodules, lymphadenopathy, peripheral and tissue eosinophilia, and markedly elevated serum IgE concentrations. Although its precise etiopathogenesis remains incompletely defined, accumulating evidence supports its classification as a type 2 immune-mediated disorder, sustained by Th2 lymphocyte activation and overexpression of interleukin (IL)-4 and IL-13 signaling pathways. This immunological milieu promotes eosinophilic infiltration, vascular proliferation, IgE overproduction, and persistent pruritus, ultimately driving both systemic and cutaneous manifestations of the disease. [...]
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dermatology Unit, San Antonio Abate Hospital, Trapani.
- Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania "Luigi Vanvitelli", Naples.
Zitieren
APA
Licata, G., Balato, A., Argenziano, G., & Giorgio, C. M. (2026). Dupilumab as a targeted therapeutic strategy for Th2-driven cutaneous manifestations in Kimura disease. Dermatology Reports. https://doi.org/10.4081/dr.2026.10839
Vancouver
Licata G, Balato A, Argenziano G, Giorgio CM. Dupilumab as a targeted therapeutic strategy for Th2-driven cutaneous manifestations in Kimura disease. Dermatology Reports. 2026. doi:10.4081/dr.2026.10839
BibTeX
@article{Licata2026,
author = {Licata, Gaetano and Balato, Anna and Argenziano, Giuseppe and Giorgio, Caterina Mariarosaria},
title = {Dupilumab as a targeted therapeutic strategy for Th2-driven cutaneous manifestations in Kimura disease},
journal = {Dermatology Reports},
year = {2026},
doi = {10.4081/dr.2026.10839}
}
EUVIMED